STEPHANIE SHEPHERD: Open Payments
NPI 1013584101 · CALHOUN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 38 payments from 5 companies in 2025. Trend: 2023 $665 · 2024 $774 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $283 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $185 |
| Insulet Corporation | 4 | $154 |
| Amgen Inc. | 4 | $60 |
| Astellas Pharma US Inc | 2 | $42 |
Products named: CAPLYTA, Omnipod, VRAYLAR, UBRELVY, Repatha, Veozah, QULIPTA, OTEZLA.
Industry payments across LA — which companies pay providers there.
